These results show that PKM2 over-expression in GBM contributes to continued tumor growth in ways consistent with the known non-metabolic activities of the protein, and that both the up-regulation of PKM2 expression and down-regulation of PKM1 expression and PK activity noted in all grades of glioma play important roles in glioma cell growth. The gene discussed is PKM; the disease is central nervous system cancer.